-
Deidentified Individual Participant Data Set (IPD)
-
Yes - There is a plan to make this available
-
Study Protocol
-
Yes - There is a plan to make this available
-
Statistical Analysis Plan
-
Yes - There is a plan to make this available
-
Informed Consent Form
-
Yes - There is a plan to make this available
-
Clinical Study Report
-
Yes - There is a plan to make this available
-
Analytic Code
-
Yes - There is a plan to make this available
-
Data Dictionary
-
Yes - There is a plan to make this available
-
Title and more details about the data/document
-
De-identified individual participant data and biomechanical data obtained from the study, including non-identifiable demographic characteristics, primary and secondary outcome data, and processed data related to the movement tasks. Data that could directly or indirectly identify participants, identifying information, and confidential medical information will not be shared with other researchers. Shareable data will be provided only after removal or de-identification of identifying information.
-
When the data will become available and for how long
-
Access to the de-identified data will begin 6 months after publication of the primary study results and will remain available for 5 years from the date of publication of the primary results.
-
To whom data/document is available
-
Qualified researchers and members of academic or research institutions with a scientifically justified request may apply for access to the data.
-
Under which criteria data/document could be used
-
The data may be used only for scientific and research purposes related to the study and following approval of the request. The data must be used in a de-identified manner and may not be used to re-identify participants, for commercial purposes, or for purposes inconsistent with research ethics principles. Applicants must specify the research objective, proposed analyses, and procedures for maintaining data confidentiality in their request.
-
From where data/document is obtainable
-
Applicants may submit data access requests to the principal investigator through the contact information provided in the Iranian Registry of Clinical Trials. The request should include the research objective, the type of data requested, and the proposed method of data use.
-
What processes are involved for a request to access data/document
-
Upon receipt of a request, the research purpose, type of data requested, proposed use of the data, and procedures for maintaining data confidentiality will be reviewed. If the request is approved, the relevant data will be de-identified and provided to the applicant after agreement on the terms of data use. Requests will generally be reviewed within 30 business days. The time required to provide the data after approval will depend on the type and volume of data requested.
-
Comments
-